76 related articles for article (PubMed ID: 28245508)
1. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.
Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM
Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508
[No Abstract] [Full Text] [Related]
2. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
3. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
6. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
7. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women.
Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L
Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236
[TBL] [Abstract][Full Text] [Related]
8. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
9. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
[TBL] [Abstract][Full Text] [Related]
10. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
11. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD
Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
[TBL] [Abstract][Full Text] [Related]
12. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma].
Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
14. P16 as a molecular biomarker of cervical adenocarcinoma.
Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
[TBL] [Abstract][Full Text] [Related]
15. P16
Ishikawa M; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Minamoto T; Sawada K; Yoshimura Y; Iida K; Razia S; Ishikawa N; Nakayama S; Otsuki Y; Kyo S
Sci Rep; 2021 Sep; 11(1):18236. PubMed ID: 34521948
[TBL] [Abstract][Full Text] [Related]
16. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
17. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
18. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
19. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
20. P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas.
Huang LW; Lee CC
J Clin Pathol; 2012 Feb; 65(2):117-21. PubMed ID: 22011452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
